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The role of the Pulmonary Function Laboratory 
has been expanded in recent years by the commercial 
development and marketing of equipment capable of 
measuring accurately and easily static lung volumes, 
diffusing capacity, and arterial blood gases. These 
sophisticated measurements, which were once the 
purview of research physiologists, are now readily 
attainable as screening measurements in most com-
m unity hospitals. This review is intended not as a 
summary of the entire field or as a technical guide for 
performance of pulmonary function tests but as a 
survey of some clinical applications and pitfalls of 
screening tests and a statement of guidelines for their 
use. It is assumed that the reader already has some 
experience in ordering and interpreting routine spiro-
grams and arterial blood gases. 
Pulmonary function tests are intended to answer 
four questions: 
1) Is the patient restricted? 
2) Is the patient obstructed? 
3) Does the patient have abnormalities of gas 
exchange? 
4) Are the observed abnormalities compatible 
with the patient's symptoms and clinical di-
agnosis? 
Restriction is a reduction of total lung capacity 
or one of its subvolumes (Fig I) as a result of collapse 
or volume displacement of the lung (fibrothorax), in-
creased elastic recoil of the lungs (pulmonary fibro-
sis), increased elastic recoil of the rib cage or abdo-
men (obesity), or loss of forces needed to overcome 
normal elastic recoil (muscular dystrophy) . It is im-
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portant to realize that a routine spirometric vital 
capacity measurement may not adequately describe 
the presence or degree of restriction. For example, 
some patients with advanced emphysema may have 
reduced vital capacity in the face of a large residual 
volume, with increased total lung capacity caused by 
obstructive air trapping; it is misleading to label such 
patients as "restricted" on the basis of reduced vital 
capacity when, in fact, they are overinflated. On the 
other hand, true early restriction may occur in the 
face of normal vital capacity. An example of this is 
obesity, a condition in which the abdominal mass 
renders the chest wall less compliant by hindering 
downward displacement of the diaphragm. The 
earliest change in the restrictive pattern of obesity is a 
marked reduction in expiratory reserve volume 
(ERV) (see Fig I) but only minor alterat.ions of the 
total lung and vital capacities. Therefore, accurate 
evaluation of patients with suspected restrictive dis-
orders should include, in addition to routine spirome-
try, a measurement of total lung capacity and its 
subdivisions by inert gas or plethysmographic tech-
niques. The following case illustrates the use of pul-
monary function studies in following the course of a 
restrictive lung disorder: 
Case I. A 53-year-old white woman developed exertional 
dyspnea and cough in 1971. A chest roentgenogram re-
vealed bilateral basilar "ground-glass" opacities. In April 
1972, an open lung biopsy showed desquamative interstitial 
pneumonia. She was placed on 20 mg prednisone daily in 
August 1972, and sequential pulmonary function tests were 
performed (Table I). The initial vital and total lung capaci-
ties were consistent with moderately severe restriction, and 
there was a correspondingly severe reduction in diffusing 
capacity. After two years of prednisone therapy, these ab-
normalities improved substantially (October 1974). When 
steroids were stopped she experienced a severe relapse 
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(February 1976) which was reversed by their resumption 
(February 1977) . In 1977 she was in remission while taking 
20 mg prednisone on alternate days·. The pulmonary June· 
tion studies provided quantitative objective evidence that a 
prolonged course of steroid therapy was necessary. 
Obstructive impairment, defined as a reduction 
in inspiratory or expiratory air-flow rates, is a result 
of intrinsic airway disease or loss of lung elastic re-
coil. The latter causes airways to lose their structural 
LUNG VOLUME 
COMPARTMENTS 
+ 
I 
I 
I 
I 
I 
I 
I 
Total Lung 
Capacity 
I 
I 
I 
Functional 
Residual 
Volume 
I 
I 
I 
t * 
I 
I 
I 
I 
I 
I 
I 
I 
lnspiratory 
Capacity 
+ 
I 
I 
Vital 
Capacity 
I 
I 
I 
I 
I 
t : 
Expiratory! 
Reserve I 
Volume I 
• I 
Residual 
Volume 
I 
* Fig 1-Spirogram with various subdivisions of total lung capacity. 
Initial deflections at left are tidal volumes recorded on slowly 
moving recording paper. Large deflection upward is inspiration to 
total lung capacity, followed by expiration to residual volume and 
resumption of tidal breathing. Residual volume is not measured 
directly, but has been previously determined by inert gas study. 
Time is on the horizontal axis, volume on the vertical. 
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support. Intrinsic airway disease may be caused by a 
variety of conditions ranging from totally reversible 
asthmatic bronchoconstriction to irreversible ad-
vanced chronic bronchitis with bronchiolitis obliter-
ans. Loss of elastic recoil almost always is a result of 
localized or generalized emphysema. 
Because the conditions causing airways obstruc-
tion tend to become more exaggerated during forced 
expiration (during which alveoli and airways are rap-
idly diminishing in both length and diameter), the 
conventional method of assessing obstructive impair-
ment is by measuring averaged flow rates on a vol-
ume-time curve of an ordinary spirogram during a 
maximally forced expiration of the vital capacity. 
(Fig 2). Although one could arbitrarily measure flow 
at a multitude of points on the curve, three measure-
ments have been standardized and used most fre-
quently (see Fig 2): the timed vital capacity (FEY 1); 
the ratio of FEY, to total vital capacity; and the 
maximum mid-expiratory flow rate (MMEF) (the av-
eraged flow over the mid-half of the vital capacity). 
Ordinarily all three measurements are made and ab-
normalities of one tend to correlate with those of the 
others. Additional measurements such as peak flow, 
total expiratory time, and forced expiratory volume 
in three seconds, or "FEY3, " add little new informa-
tion but may be sensitive indicators of changes when 
evaluating drug effects in population samples. 
Obstruction is conventionally quantitated dur-
ing expiration; however, patients develop dyspnea 
from obstructive impairment because of the increased 
work of breathing during inspiration. In most cases, 
obstruction during inspiration is inferred by abnor-
malities in the FEY, and MMEF; unfortunately, 
there are several important exceptions to this. Indi-
viduals with obstruction isolated to the trachea or 
larynx (for example, tracheomalacia following endo-
tracheal intubation) may not have evidence of ex-
TABLE I 
Sequential Function Studies in a Patient with Desquamative 
Interstitial Pneumonia. 
August October February February Pre· 
1972 1974 1976 1977 dieted 
Vital capacity, 
liters 2.06 3.45 2.30 3.12 3.97 
Total lung 
capacity, 
liters 3.55 5.24 3.79 4.95 6.32 
Arterial Po,, 
torr 66 73 67 76 90 
Diffusing capacity, 
ml/ min/ torr 8.5 17.0 7.9 11 .2 22.0 
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Fig 2-Forced vital capacity shown on rapidly movlng recording 
paper. Total downward excursion of curve (vertical axis) is vital 
capacity. Volume exhaled during the first second is FEY,. MMEF 
is slope of line connecting points A and B. Time is on the horizon-
ta l axis. 
piratory obstruction if their defect is a bove the tho-
racic outlet, or they m ay h ave spirometric 
abnormalities which are misinterpreted as general-
ized airways obstruction if their defect is below the 
thoracic outlet. In addition, individuals with sub-
stanti al narrowing of bronchioles but no rmal patency 
of bronchi (for example, young smokers with early 
chronic bronchitis) may have completely normal 
spiro metric flow rates but isolated a bnormalities of 
MM EF which are difficult to interpret because of the 
large standard deviation of this test in the normal 
population. 
When either of these exceptions is suspected, 
additiona l information may be obtained by a record-
ing of a flow-v ol ume curve, or graphical representa-
tion of instantaneous mouth flow and expired volume 
during a forced inspiration and expiration of the vital 
capacity (Fig 3 ). The normal configuration of this 
curve is shown in Figure 3a. Fixed obstruction in the 
trachea produces a characteristic fixed limitation to 
flow which is independent of volume (Fig 3b ). An 
additional advantage of the flow-volume curve is its 
depiction of inspiratory events, thus faci litating the 
detection of variable extrathoracic upper-airway ob-
struction (Fig 3c ). Generalized bronchiolar narrow-
ing produces flow limitations which are detectable 
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Fig 3a-l nspiratory-expiratory flow-volume curve shows normal 
configurat ion in a 28-year-old man . 
Fig 3b-Fixed upper-airway obstruction seen in a 32-year-old man 
with stenosis of intrathoracic trachea. 
Fig Jc- Curve shows variable extrathoracic obstruction as a result 
of loss of carti lagenous tracheal support in the subglottic region. 
The weakened area collapses on inspiration but is distended during 
expiration by positive airway pressure. 
Fig 3d- " I nwardly concave" distortion of the exp ired cu rve at 
lower lu ng vo lumes is seen in a 30-year-old chronic cigarette 
smoker wit h a normal spirograni. The distortion is due to 
bronchiolar obstruction. 
only on expiration at lower lung volumes and tend to 
worsen as volume diminishes. This will result in an 
"inwardly concave" ap pearance to the flow-volume 
curve in patients with obstruction limited to the bron-
chioles (Fig 3d). It should be pointed out that this 
"inwardly concave" configuration is not specific for 
periphera l sma ll airways obstruction; if the spiro-
gram also indicates obstruction, the curve is not use-
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fut for differentiating generalized obstruction from 
that isolated to peripheral airways. The following 
case is an example of obstructive impairment and 
also illustrates the value of lung volume determina-
tions by the helium dilutional method in differentia-
ting obstructive from restrictive impairment: 
Case 2. A 19-year-old male gas station attendant abruptly 
developed exertional dyspnea in January 1976. Seven 
months later a carefully taken history revealed that he had 
been caring for his brother's homing pigeons since late 
December 1975. The ·chest roentgenogram was normal , 
although symptoms persisted. Pulmonary function studies 
(Table 2, July 1976) revealed a reduced vital capacity; 
however, the total lung capacity and residual volume sug-
gested probable obstructive air trapping rather than restric-
tion. The FEV1 and MMEF confirmed obstruction. With-
out specific treatment other than ceasing the pigeon 
exposure, his symptoms resolved and objective improvement 
was evident on sequential studies ( September 1976). Al-
though both restriction and obstruction may occur in a ller-
gic alveolitis, restriction is usually the dominant impair-
ment. However, in this patient 's case, obstruction occurred 
without restriction. 
Arterial hypoxemia is a sequela of impaired gas 
exchange; however, measurement of resting arterial 
oxygen tension (Po2) alone may not be sufficiently 
sensitive to detect such impairment. Impaired gas 
exchange is also present if there is an increase in the 
observed oxygen tension difference between alveolar 
air and arterial blood (DA-a 0 2) or if there is an 
abnormality in the diffusing capacity for carbon 
monoxide. For ambulatory patients breathing room 
air, DA-a 0 2 can be estimated by obtaining a sample 
of arterial blood under steady-state conditions. Al-
veolar oxygen tension is calculated by the standard 
alveolar air equation: 
PA02 = F102(713) = Paco2 (F10 2 + 1 -;0°2) 
F102 = fraction of02 in inspired air 
Paco2 arterial Pco2 (identical to mean alveolar 
Pco2) 
RQ = respiratory quotient 
The achievement of steady-state conditions is an es-
sential prerequisite for this test because the estima-
tion of alveolar oxygen tension is based on the as-
sumption that the ratio of C02 produced to 0 2 
consumed (RQ) is 0.8. Transient hyperventilation 
caused by anxiety or pain will invalidate this assump-
tion. Direct measurement of RQ may provide a more 
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TABLE 2 
Sequential Function Studies in a Patient with Allergic Alveol-
itis Due to Pigeon Exposure. 
July September 
1976 1976 Predicted 
Vital capacity, 
liters 3.98 4.42 5.62 
Total lung 
capacity, liters 6.95 6.68 7.34 
Residual volume, 
liters 2.97 2.26 1.72 
FEY 1 , liters 2.51 3.09 4.54 
FEV 1/ Vital 
Capacity,% 63 70 80 
MMEF, liters/ sec. 1.24 2.03 4.90 
refined estimation of PA 0 2; however, this also re-
quires sampling under steady-state conditions. For 
either approach, hyperventilation may be avoided by 
inserting an arterial cannula and allowing the patient 
to rest prior to sample collection. 
The measurement of carbon monoxide diffusing 
capacity by the simplified single-breath technique re-
quires the patient to breath hold at total lung capacity 
for ten seconds. Patients who are markedly dyspneic 
at rest may not be able to perform this test. Despite 
these limitations, useful results are forthcoming for 
most cooperative subjects. 
The precise pathophysiologic explanation for 
impaired diffusion of carbon monoxide in lung dis-
eases is unknown. Most authorities agree that it is a 
sign of alveolar or capillary destruction. Therefore, 
impaired CO uptake may occur in parenchymal de-
structive processes such as idiopathic fibrosing al-
veolitis, scleroderma, advanced sarcoidosis, and in 
vascular obliterative processes such as idiopathic pul-
monary hypertension or multiple small pulmonary 
emboli. It is also impaired in processes causing re-
versible loss of functioning alveoli, examples of which 
are bacterial pneumonia and alveolar proteinosis. CO 
uptake is impaired in generalized emphysema due to 
emphysematous destruction of alveoli but remains. 
nearly normal in chronic bronchitis because the de-
structive process is confined to airways and centri-
lobular elements of the parenchyma. Diffusing capac-
ity may be spuriously impaired by several conditions. 
The first is the presence of severe anemia, which 
limits the availability of hemoglobin CO receptors; 
the second is that failure to achieve true total lung 
capacity during the breathhold will reduce CO up-
take in proportion to the reduction in potential lung 
volume. The following case illustrates the value of the 
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TABLE 3 
Pulmonary Function Studies in a Patient with Sarcoidosis 
0 2 were also normal. However, a moderately severe reduc-
tion in diffusing capacity suggested the presence of wide-
spread interstitial disease despite the clear roentgenographic 
lung fields. Hemoglobin was normal. A transbronchoscopic 
lung biopsy showed interstitial non-caseating granulomata 
consistent with sarcoidosis. 
September 1978 Predicted 
Vital capacity, liters 2.98 3.63 
FEY" liters 2.68 2.88 
FEY/vital 
capacity,% 90 79 
MMEF, 
liters/second 4.03 3.37 
Total lung capacity, 
liters 3.85 5.12 
Residual volume, 
liters .76 1.49 
Pao,, torr 92 90 
DA-a 0 2 , torr 13 15 
Diffusing capacity, 
ml/ min/ torr 12.0 21.7 
diffusing capacity in screening patients for the pres-
ence of gas exchange impairment: 
Although measured impairment in pulmonary 
function frequently provides an objective explanation 
for the presence of dyspnea, many patients may expe-
rience this symptom because of abnormalities which 
are undetectable on screening evaluations. Negative 
screening studies should stimulate a careful search for 
vascular disease or nonpulmonary causes of dyspnea. 
For example, "metabolically justified" hyperpnea 
and dyspnea may accompany hyperthyroidism; pa-
tients with mitral stenosis or early congestive heart 
failure may have only mild impairment in lung me-
chanics despite severe exertional dyspnea; and pa-
tients with partial obliteration of the pulmonary vas-
culature may have normal lung mechanics, arterial 
oxygen tensions, and diffusing capacities while at 
rest, only to show abnormalities during exercise. 
Cas~ 3. A 32-year-old woman complained of mild ex-
ertional dyspnea of two months duration. Chest roentgeno-
gram q:vealed bilateral hilar adenopathy. Pulmonary func-
tion studies (Table 3) showed a modest reduction in total 
lung capacity (75% predicted) with normal vital capacity 
anq flow rates. Resting arterial oxygen tension and DA-a 
For a variety of vascular and interstitial pul-
monary disorders, it may be appropriate to evaluate 
TABLE 4 
Guidelines for Ordering Medical or Surgical Screening Pulmonary Function Studies. 
I. Asymptomatic non-smoker 
2. Asymptomatic smoker 
3. Heavy smoker with dyspnea and/ or chronic bron-
chitis 
4. Young asthmatic 
5. "Old" asthmatic (> 30 years) 
6. Suspected tracheal obstruction, stridor, or unex-
plained obstruction on a previous spirogram 
7. Suspected interstitial lung disease 
8. Suspected pulmonary vascular disease 
9. Suspected a natomic right-to-left shunt 
I 0. Suspected early small-airways disease 
No studies; "routine spirogram" (vital capacity, FEY" MMEF) if thoracic 
surgery is planned. 
Routine spirogram; add resting arterial blood gases if thoracic surgery is 
planned. 
Routine spirogram; total lung capacity; diffusing capacity; resting arterial 
blood gases. 
Spirogram before and after an inha led bronchodilator. 
Spirogram before and after inhaled bronchodilator; tota l lung capacity: resting 
arterial blood gases. 
lnspiratory and expiratory flow-volume curve. 
Spirogram; total lung capacity; diffusing capacity; steady-state arteria l blood 
gases with DA-a 0 2 • 
Same as #7. Add exercise DA-a 0 2, physiologic deadspace, end tidal CO, 
gradient. 
Arteria l blood gases whi le breathing I 00% 0 2 • This study should never be 
requested for patients with emphysema or chronic bronchitis who have CO, 
retention. 
In view of the limited clinical benefits, adequate evaluation is too expensive. 
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physiology during exercise as resting abnormalities 
frequently are exaggerated during exercise. However, 
pulmonary exercise testing, unlike cardiac stress test-
ing, should provide a graded low level of exercise 
(doubling or tripling of the oxygen uptake) rather 
than maximum stress. In fact, recent experimental 
evidence' has suggested that maximum stress mea-
surements are potentially misleading because normal 
subjects may demonstrate transient abnormalities in 
Pao2 and DA-a 0 2 while performing temporary but 
severe tasks such as rapid stair-climbing. Although a 
complete discussion of exercise physiology testing is 
beyond the scope of this paper, som'e recent reviews 
of the relevance of pulmonary exercise testing in clini-
cal medicine are included in the bibliography.1-2 
Table 4 is a suggested modus operandi for order-
ing screening pulmonary function studies for specific 
problems. Physicians ordering such tests must realize 
that measurements of lung mechanics require both 
cooperation apd effort. Too much testing at a sing!~ 
sitting may fatigue the patient and cause spuriously 
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abnormal results. For example, it would be unwise to 
subject a patient to both screening studies and exer-
cise physiology studies for suspected vascular disease 
on the same day. Therefore, in the context of the 
suggestions in Table 4, clinical wisdom and common 
sense should dictate which tests are appropriate for 
individual patients. . 
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